System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Emilie Sbidian is an expert in Dermatology at Hôpitaux Universitaires Henri-Mondor (France). As of October 2026, ScienceLeadR ranks Emilie Sbidian in the top 1% of experts worldwide for Psoriasis, Sexually Transmitted Diseases and Skin Diseases, Papulosquamous. Emilie Sbidian has authored 439 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 1,380 (community average: 125). How the SLR is computed.

LeadR Profile

Emilie Sbidian Hôpitaux Universitaires Henri-Mondor France
1 380 ScienceLeadR Reputation 1380

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Public Health - Rheumatology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Université Paris Cité

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 439

Citations

Citations: 5 946 1st author: 48 Last author: 92 Unique author: 4

Main journals

Ann Dermatol Venereol 124
Br J Dermatol 48
J Eur Acad Dermatol Venereol 32
Annales de Dermatologie et de Vénéréologie - FMC 25
Annales de dermatologie et de vénéréologie, FMC 22

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Robustness of Network Meta-Analysis in Chronic Plaque Psoriasis.
PMID 42776554 — network meta-analysis, psoriasis		JAMA Dermatol20260
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.
PMID 42424135 — genes, rna editing, psoriasis, rna		J Exp Med20262
Risk of Cancer according to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study from the French Health Insurance Database.
PMID 42605840 — hematologic neoplasms, neoplasms, arthritis, cohort studies, insurance, insurance, health, rheumatic diseases, therapeutics, snds		Arthritis Rheumatol20260
Cutaneous tuberculosis masquerading as sarcoidosis in an immunocompetent migrant.
PMID 42439448 — travel, sarcoidosis, global health, tuberculosis, tuberculosis, cutaneous, lupus vulgaris		J Travel Med20260
Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors.
PMID 42241024 — sexually transmitted diseases, cohort studies, skin diseases, prevalence, risk factors, diagnosis		J Eur Acad Dermatol Venereol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 2
Phase 2 1
Phase 3 1

By status:

Completed 2
Not yet recruiting 1
Unknown 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications a Cohort Study of Patients With pSOriasis
NCT06055699 — intestines, blood, serum, cohort studies, metagenomics, immunity, research, therapeutics, ethanol, psoriasis, gastrointestinal microbiome, dna, communicable diseases, biological factors, temperature, microbiota, infections, rna		N/ANot yet recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS